FDA OKs iCAD's breast density AI software

Computer-aided detection (CAD) developer iCAD has received clearance from the U.S. Food and Drug Administration (FDA) for the latest version of its PowerLook Density Assessment artificial intelligence (AI) software.

PowerLook Density Assessment version 3.4 is designed for automated and reproducible assessments of breast density to identify patients with dense breast tissue and subsequent reduced sensitivity to digital mammography.

The software is compatible with the company's digital breast tomosynthesis (DBT) platform on both GE Healthcare and Hologic systems.

Page 1 of 569
Next Page